The Brighterside of News on MSN2h
Groundbreaking clinical trial cures cancer in 100% of patientsIn a clinical trial involving 14 participants, immunotherapy on its own effectively eradicated rectal cancer. This ...
“Time Off for Clinical Trials," launched on Nov. 20, sees six of BioNJ’s biggest members—Amicus Therapeutics, Bristol Myers ...
A recent discussion with BDO's clinical trials editor and Audrey Davis of CSC, discussed strategies to increase clinical ...
A new type of therapy that "edits" a gene in patients with a rare heart condition has been shown to be safe and effective, ...
A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients ...
Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...
During the Phase III BROOKLYN trial, patients were randomly assigned in a 2:1 ratio to receive either obicetrapib 10mg or a ...
The bidirectional research examines both laboratory findings and human clinical trial data, revealing that the medicinal use ...
The National Institutes of Health (NIH) has unveiled a new artificial intelligence (AI) algorithm designed to more ...
Viking Therapeutics (VKTX) announced that final results from the company’s Phase 2b clinical trial of VK2809, the company’s novel ...
Backed by a Strong Balance Sheet, MIRA Accelerates Toward Becoming a Clinical-Stage Company and Advancing Breakthroughs in Pain and Depression Treatment ...
An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback